Best Practice & Research Clinical Rheumatology
Volume 20, Issue 1 , Pages 69-80, February 2006

Do biochemical markers have a role in osteoarthritis diagnosis and treatment?

  • Virginia B. Kraus, PhD, MD (Associate Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +1 919 681 6652; Fax: +1 919 684 8907.

Division of Rheumatology, Duke University Medical Center, Box 3416, Durham, NC 27710, USA

It is possible to use biomarkers in cohort studies and in clinical trials to increase our understanding of disease, to elucidate disease mechanisms, and to bolster a clinical impression of the disease state of osteoarthritis. Whether it will be possible to utilize biomarkers meaningfully to characterize the disease state in an individual patient remains to be seen. Major concepts related to the use of biomarkers for research and clinical practice, and factors influencing biomarker concentrations, are described in this review in order to address the potential role of biomarkers in osteoarthritis diagnosis, prognosis, and treatment.

Key words: biomarkers, osteoarthritis, disease trajectory, systems-based approach

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(05)00102-6

doi:10.1016/j.berh.2005.09.001

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 1 , Pages 69-80, February 2006

Article Tools

* Image Usage & Resolution